Galmed Pharmaceuticals Ltd. buy Royal Bank of Canada
Start price
07.08.24
/
50%
€0.26
Target price
07.08.25
€71.40
Performance (%)
1269.23%
Price
16:17
€3.56
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada for Galmed Pharmaceuticals Ltd. has seen massive gains of 1269.23%. This prediction currently runs until 07.08.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Galmed Pharmaceuticals Ltd. | 5.806% | 5.806% |
iShares Core DAX® | -0.168% | 4.802% |
iShares Nasdaq 100 | 2.946% | 3.520% |
iShares Nikkei 225® | 1.319% | 6.746% |
iShares S&P 500 | 2.044% | 3.551% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Royal Bank of Canada from $76.00 to $78.00. They now have an "outperform" rating on the stock.
Ratings data for GMED provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.41
11.01.24
11.01.24
€63.93
11.01.25
11.01.25
740.58%
16:17
16:17